Background and Aims: A reliable and valid dyspnea assessment scale for patients who are unable to express themselves is lacking in Taiwan. This study is conducted to develop a Chinese version of the Respiratory Distress Observation Scale (C-RDOS) and test its reliability and validity.
Background and Aims: A reliable and valid dyspnea assessment scale for patients who are unable to express themselves is lacking in Taiwan. This study is conducted to develop a Chinese version of the Respiratory Distress Observation Scale (C-RDOS) and test its reliability and validity.
Methods: This study was conducted in two phases. The first phase entailed creating the C-RDOS in compliance with well-known guidelines. The second phase involved adopting a cross-sectional study design to test the internal consistency reliability, criterion and discriminant validity of the C-RDOS by using 80 intubated COPD patients, 80 orthopaedic surgery patients, and 80 healthy individuals. The 4-point verbal descriptor scale (VDS), peripheral oxygen saturation (SPO2), and the 11-point numerical rating pain scale were used to assess subject' s dyspnea and pain.
Results: C-RDOS was established with the good content validity (item-CVI of 1.0 and scale-CVI of 1.0). The inter-rater reliability among five evaluators was excellent (Kendall's W = 0.982, P < .001). The C-RDOS also displayed a good internal consistency reliability (Cronbach's α of 0.81). In testing the criterion validity, subject's C-RDOS scores and SpO2 were negatively correlated (r = 0.42, P < .001), whereas their C-RDOS and VDS scores were positively correlated (r = 0.89, P < .001).
The discriminant validity was presented by, after controlling for heart rate, subjects' pain scores were non-correlated with the C-RDOS scores (r = 0.279, P = .205).
Conclusion:
The C-RDOS has been established with good reliability and validity. The C-RDOS can be used in clinics in Taiwan. Background and Aims: Hypernatremia is common in patients admitted to the intensive care unit (ICU) and is associated with higher disease severity and mortality rates. We aimed to determine whether hypernatremia associated with higher mortality rate independent of disease severity using propensity score matching. We also tried to elucidate the impact of correctability of hypernatremia and acquired hypernatremia on mortality. Finally, association of hypernatremia with immune dysfunction was examined using 2 different methods. Impaired immune responses were determined using monocyte surface protein expression of human leukocyte antigen DR and fold change of cytokine level after lipopolysaccharide (LPS) stimulation of peripheral blood mononuclear cells.
Results: Hypernatremia was noted in 9.8% (51 of 520) of patients at the day of ICU admission. Patients with hypernatremia are older (71.8 vs 66.0 y/o, P = 0.010) and had higher sequential organ failure assessment (SOFA) score (10.9 vs 9.2, P = 0.040). We used 1:3 propensity score matching to balance age and SOFA score between hypernatremia and non-hypernatremia patients. A total of 190 patients (50 hypernatremic, 140 non-hypernatremic) were included into final analysis. Patients with hypernatremia had higher mortality rates than those without (14-day mortality, relative risk [RR]: 1.30, 95% CI: 1.02-1.65; 28-day mortality, RR: 1.36, 95% CI: 1.04-1.79; 90-day mortality, RR: 1.46, 95% CI: 1.02-2.11). Patients with persist hypernatremia at both day 1 and 3 had higher mortality rates than those without hypernatremia at both day 1 and 3 (log rank P = 0.028). Decreased immune responses after LPS stimulation were noted in patients with hypernatremia (Medium Fold change of granulocyte-colony stimulating factor: 0.99 vs 2.45, P = 0016; tumor necrosis factor: 1.93 vs 2.81, P = 0.031) Conclusion: Hypernatremia in critically ill sepsis patients are associated with impaired immune response and increased mortality risk. Background and Aims: In recovering ARDS patients, lung collapse frequently occurs, especially after PEEP reduction. However, factors predicting this event have not been established. Endotracheal suction commonly causes temporary oxygen desaturation and lung de-recruitment. We hypothesized that lung collapse after suction was possibly associated with lung collapse event after PEEP decrement. This study aimed to compare time to lung volume recovery after suction between ARDS patients with and without lung collapses after PEEP reduction.
Methods:
We conducted a prospective observational study in recovering ARDS patients. We enrolled the patients who were assisted with either PCV or VCV mode, and using PEEP of ≥ 8 cmH 2 O without ventilator adjustment for > 12 h. All patients had stable oxygenation and hemodynamic. We assessed time to lung volume recovery by using electrical impedance tomography. Time to lung volume recovery was defined as the duration from endotracheal suction to time that end expiratory lung volume returned to the baseline, and the lung collapse event was defined as the event that SpO2 decreased by ≥ 3 % or PaO 2 decreased by ≥ 10% after PEEP reduction. A study protocol showed in Figure 1 .
Results: Totally, 15 endotracheal suctions followed by decremental PEEP procedures were performed in 7 patients. The patients had median age of 69 [67, 81] , median APACHE II of 15 [13, 20] , median PEEP of 10 [8,12] cmH2O and median respiratory system compliance of 24.5[9.9, 35 .4] mL/cmH 2 O. Three lung collapse events (20%) appeared after PEEP reduction. The median time to lung volume recovery after suction tended to be longer in the patients with lung collapse after PEEP reduction ─180 [38, 800] milliseconds in lung collapse VS 29.5[10.75, 159] milliseconds in non-collapse.
Conclusion:
Time to lung volume recovery after endotracheal suction might predict the lung collapse event after PEEP reduction in recovering ARDS patients. Further studies should be conducted to confirm our results.
